- €555.40m
- €550.93m
- €219.79m
- 88
- 43
- 11
- 42
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.79 | ||
| PEG Ratio (f) | 0.6 | ||
| EPS Growth (f) | 27.31% | ||
| Dividend Yield (f) | 3.25% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.61 | ||
| Price to Tang. Book | 8.17 | ||
| Price to Free Cashflow | 18.35 | ||
| Price to Sales | 2.58 | ||
| EV to EBITDA | 8.82 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.39% | ||
| Return on Equity | 20.74% | ||
| Operating Margin | 22.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 158.57 | 171.75 | 193.07 | 214.07 | 219.79 | 216 | 236 | 8.16% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +6.31 | +13.7 | +27.37 | +19.47 | +0.66 | -26.79 | +27.31 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Equasens SA is formerly known as Pharmagest Interactive SA is a France-based company. The Company is engaged in publishing and integration of software packages intended for pharmacies, hospitals, health establishments, laboratories, retirement homes and health professionals. Its activity is distributed in publishing and integration of software packages for pharmacies, publishing of IT solutions for health and medico-social establishments and development of solutions and infrastructure for e-Health. It provides software packages for managing databases, information, stocks, orders, electronic care sheets, etc. It offers publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, invoicing, tracking collections and accounting, care monitoring, stewardship management, etc.);
Directors
- Thierry Chapusot CHM (62)
- Denis Supplisson DCE (85)
- Dominique Pautrat MDR (56)
- Gregoire de Rotalier DMD (50)
- Daniel Antoine DRC (69)
- Francois Jacquel DRC (62)
- Emilie Lecomte DRC (43)
- Anne Lhote DRC (53)
- Hugues Moreaux DRC (68)
- Celine Gris IND (44)
- Marie-louise Liger IND (69)
- Sophie Mayeux IND (64)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- January 1st, 1996
- Public Since
- October 20th, 2000
- No. of Employees
- 1,240
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
Euronext - Paris- Shares in Issue
- 15,031,194
- Address
- 5 Allee de Saint-Cloud, VILLERS LES NANCY, 54600
- Web
- https://equasens.com/
- Phone
- +33 383159595
- Auditors
- Batt Audit
Upcoming Events for EQS
Equasens SA Annual Shareholders Meeting
Equasens SA Annual Shareholders Meeting
Q2 2025 Equasens SA Corporate Sales Release
Half Year 2025 Equasens SA Earnings Release
Half Year 2025 Equasens SA Earnings Presentation
Similar to EQS
74Software SA
Euronext - Paris
Acteos SA
Euronext - Paris
Alten SA
Euronext - Paris
Atos SE
Euronext - Paris
Aubay SA
Euronext - Paris
FAQ
What is the Equasens SA share price?
As of Today at 20:29 UTC, shares in Equasens SA are trading at €36.95. This share price information is delayed by 15 minutes.
How has the Equasens SA share price performed this year?
Shares in Equasens SA last closed at €36.95 and the price had moved by -37.9% over the past 365 days. In terms of relative price strength the Equasens SA share price has underperformed the FTSE Global All Cap Index by -39.45% over the past year.
What are the analyst and broker recommendations for Equasens SA?
The overall consensus recommendation for Equasens SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Equasens SA dividend yield?
The Equasens SA dividend yield is 3.38% based on the trailing twelve month period.
Does Equasens SA pay a dividend?
Last year, Equasens SA paid a total dividend of €1.25, and it currently has a trailing dividend yield of 3.38%. We do not have any data on when Equasens SA is to next pay dividends.
When does Equasens SA next pay dividends?
We do not have data on when Equasens SA is to next pay dividends. The historic dividend yield on Equasens SA shares is currently 3.38%.
How do I buy Equasens SA shares?
To buy shares in Equasens SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Equasens SA?
As of the previous close price of €36.95, shares in Equasens SA had a market capitalisation of €555.40m.
Where are Equasens SA shares listed?
Here are the trading details for Equasens SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: EQS
What kind of share is Equasens SA?
Based on an overall assessment of its quality, value and momentum Equasens SA is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Equasens SA share price forecast for 2025?
The analyst consensus target price for shares in Equasens SA is €59.50. That is 61.03% above the last closing price of €36.95.
Analysts covering Equasens SA currently have a consensus Earnings Per Share (EPS) forecast of €2.27 for the next financial year.
Find out moreWhat is the trend in the Equasens SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Equasens SA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -25.83%.
As of the last closing price of €36.95, shares in Equasens SA were trading -14.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Equasens SA PE Ratio?
The Equasens SA PE ratio based on its reported earnings over the past 12 months is 12.79. The shares last closed at €36.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Equasens SA?
Equasens SA's management team is headed by:
- Thierry Chapusot - CHM
- Denis Supplisson - DCE
- Dominique Pautrat - MDR
- Gregoire de Rotalier - DMD
- Daniel Antoine - DRC
- Francois Jacquel - DRC
- Emilie Lecomte - DRC
- Anne Lhote - DRC
- Hugues Moreaux - DRC
- Celine Gris - IND
- Marie-louise Liger - IND
- Sophie Mayeux - IND